Globus Medical (GMED)

Currency in USD
93.70
-1.17(-1.23%)
Closed·
98.50+4.80(+5.12%)
·
Unusual Post-Market activity
Earnings results expected in 0 days
GMED is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
93.3995.68
52 wk Range
51.79101.40
Key Statistics
Prev. Close
93.7
Open
94.68
Day's Range
93.39-95.68
52 wk Range
51.79-101.4
Volume
796.16K
Average Volume (3m)
1.09M
1-Year Change
29.7665%
Book Value / Share
34.17
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
GMED Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
110.08
Upside
+17.48%
Members' Sentiments
Bearish
Bullish
ProTips
Management has been aggressively buying back shares

Globus Medical News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices; treatment options for motion preservation technologies consisting of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and biologic solutions, such as allografts and synthetic alternatives. It also provides orthopedic trauma solutions, including limb reconstruction, fracture plating, intramedullary nailing, external fixation, and compression screw technologies; hip and knee arthroplasty solutions, including modular cement and cementless hip stems, acetabular cups, femoral heads, highly cross-linked liners, partial knee systems, cruciate retaining, posterior stabilized, and revision options; spinal cord stimulation services; and neuromonitoring services, which provide onsite and remote monitoring of the neurological systems. In addition, the company offers ExcelsiusGPS platform, a robotic guidance and navigation system for minimally invasive and open procedures; Surgimap, a surgical planning software platform; Excelsius3D, a platform combined with ExcelsiusGPS that provides an intraoperative and image-guided robotic navigation solution; ExcelsiusHub, which provides real-time patient array monitoring, tissue sparing drills, and registration flexibility; and ExcelsiusFlex, a total knee arthroplasty robotic solution. Further, it distributes human cells, tissues, and cellular and tissue-based products. The company sells its products through direct and distributor sales representatives; and independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Globus Medical SWOT Analysis


Robotic Spine Leade
Globus Medical dominates the robotic spine surgery sector with innovative technologies like the Excelsius platform, driving substantial revenue growth
Strategic Acquisitions
Explore Globus Medical's market expansion through the NuVasive merger and Nevro acquisition, positioning it as a comprehensive musculoskeletal solutions provide
Financial Strength
Discover Globus Medical's robust financial performance, with record free cash flow and raised guidance for 2024, reflecting its strong market position
Analyst Optimism
Learn about analyst price targets ranging from $95 to $103, reflecting confidence in Globus Medical's growth potential and fair valuation
Read full SWOT analysis

Globus Medical Earnings Call Summary for Q3/2025

  • Globus Medical reported Q3 2025 EPS of $1.18, exceeding forecasts by 51.28%, with revenue of $769 million (up 22.9% YoY), driving a 1.97% aftermarket stock increase
  • The company achieved record Q3 free cash flow of $213.9 million and a 32.8% consolidated adjusted EBITDA margin, with strong performance in spine and trauma markets
  • Integration of Nevro has strengthened Globus Medical's portfolio, with new product launches in extended reality and robotics expanding market reach
  • Management raised 2025 guidance, projecting net sales of $2.86-2.9 billion (13.5-15.1% growth) and non-GAAP EPS of $3.75-3.85 (23.2-26.5% growth)
  • CEO Keith Pfeil outlined a strategic focus on innovation and operational excellence, with long-term goals to achieve mid-70% gross margins and mid-30s EBITDA margin
Last Updated: 2025-11-06, 06:02 p/m
Read Full Transcript

Compare GMED to Peers and Sector

Metrics to compare
GMED
Peers
Sector
Relationship
P/E Ratio
23.6x4.8x−0.5x
PEG Ratio
0.06−1.020.00
Price/Book
2.8x3.8x2.6x
Price / LTM Sales
4.3x2.8x3.2x
Upside (Analyst Target)
21.6%76.0%47.4%
Fair Value Upside
Unlock22.3%6.9%Unlock

Analyst Ratings

10 Buy
4 Hold
0 Sell
Ratings:
14 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 110.08
(+17.48% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Wells Fargo
Buy104.00+10.99%98.00MaintainFeb 26, 2026
TD Cowen
Buy112.00+19.53%110.00MaintainFeb 25, 2026
Needham
Buy114.00+21.66%112.00MaintainFeb 25, 2026
Jefferies
Buy120.00+28.07%115.00MaintainFeb 25, 2026
Truist Securities
Buy115.00+22.73%105.00MaintainFeb 25, 2026

Earnings

Latest Release
Feb 24, 2026
EPS / Forecast
1.28 / 1.11
Revenue / Forecast
826.4M / 792.72M
EPS Revisions
Last 90 days

GMED Income Statement

People Also Watch

49.050
LTM
-1.90%
263.43
LH
-0.14%
76.01
OMC
+0.36%
87.92
FLS
+5.65%

FAQ

What Is the Globus Medical (GMED) Stock Price Today?

The Globus Medical stock price today is 93.70 USD.

What Stock Exchange Does Globus Medical Trade On?

Globus Medical is listed and trades on the New York Stock Exchange.

What Is the Stock Symbol for Globus Medical?

The stock symbol for Globus Medical is "GMED."

What Is the Globus Medical Market Cap?

As of today, Globus Medical market cap is 12.71B USD.

What Is Globus Medical's Earnings Per Share (TTM)?

The Globus Medical EPS (TTM) is 3.92.

When Is the Next Globus Medical Earnings Date?

Globus Medical will release its next earnings report on May 07, 2026.

From a Technical Analysis Perspective, Is GMED a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Globus Medical Stock Split?

Globus Medical has split 0 times.

How Many Employees Does Globus Medical Have?

Globus Medical has 6000 employees.

What is the current trading status of Globus Medical (GMED)?

As of Apr 28, 2026, Globus Medical (GMED) is trading at a price of 93.70 USD, with a previous close of 93.70 USD. The stock has fluctuated within a day range of 93.39 USD to 95.68 USD, while its 52-week range spans from 51.79 USD to 101.40 USD.

What Is Globus Medical (GMED) Price Target According to Analysts?

The average 12-month price target for Globus Medical is 110.08 USD, with a high estimate of 123 USD and a low estimate of 90 USD. 10 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +17.48% Upside potential.

What Is the GMED After Hours Price?

GMED's last after hours stock price is 98.50 USD, the stock has decreased by 4.80, or 5.12%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.